Gait Rehabilitation to Treat FastOA
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Apr 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special type of feedback about walking, called gait biofeedback, can help young patients recover from knee injuries, specifically those who have had surgery to repair their anterior cruciate ligament (ACL). The main goal is to see if this feedback can improve early signs of a condition known as FastOA, which is a type of arthritis that can develop after an injury. The trial will last for 6 weeks, and participants will be checked again after 6 months to see how they are doing.
To join the study, participants should be between 16 and 35 years old and must have had ACL surgery at least 6 months but no more than 5 years ago. They should also have finished all other physical therapy and show specific patterns in their walking. People with certain knee issues, or those who are significantly overweight, are not eligible. If you join this trial, you can expect to receive personalized feedback on your walking over the course of 6 weeks, which could help improve your recovery and overall knee health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have completed all other formal physical therapy
- • Are between the ages of 16 and 35
- • Underwent an anterior cruciate ligament reconstruction (ACLR) between 6 and 60 months prior to enrollment
- • Demonstrate underloading during gait (vGRF- impact peak \<1.12 x BW)
- Exclusion Criteria:
- • A multiple ligament surgery (i.e., PCL)
- • A lower extremity fracture (i.e., displaced tibial plateau fracture)
- • Knee osteoarthritis
- • The participant has a BMI ≥ 36.
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Brian Pietrosimone, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported